Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Congenital Heart Disease (CHD) Market Expected To Expand Between 2025 And 2029?
The congenital heart disease (chd) market size has experienced strong growth in recent years. It is forecast to expand from $4.42 billion in 2024 to $4.85 billion in 2025, at a compound annual growth rate (CAGR) of 9.7%. The market’s historical growth can be linked to a higher incidence of risk factors like obesity and smoking, advancements in diagnostic technologies, an enlarging geriatric population, more effective awareness campaigns, improved reimbursement policies, and increased spending on research and development.
The market size for congenital heart disease (chd) is expected to demonstrate robust expansion over the coming years. It is projected to achieve $6.82 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.9%. This anticipated growth during the forecast period can be attributed to several factors: broadening access to healthcare services in developing regions, ongoing innovation in cardiac imaging technologies, increasing awareness campaigns designed to promote early detection and treatment, a global rise in healthcare expenditure, and advancements in personalized medicine. Prominent trends identified for the forecast period include the increasing adoption of minimally invasive surgical techniques, an expanded utilization of telemedicine for remote patient monitoring and consultations, a growing demand for customized treatment approaches, the development of innovative implantable devices featuring enhanced functionality and longevity, and the integration of artificial intelligence and machine learning into both diagnostic and therapeutic processes.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15545&type=smp
What Are The Key Drivers Of Growth In The Congenital Heart Disease (CHD) Market?
Rising instances of maternal diabetes are anticipated to fuel the expansion of the congenital heart disease (CHD) market moving ahead. Maternal diabetes, also known as gestational diabetes mellitus (GDM), is defined as diabetes that develops during pregnancy in individuals who were not diabetic prior to becoming pregnant. This condition stems from lifestyle alterations, such as a lack of physical activity and poor eating patterns, coupled with a general increase in obesity levels among women in their reproductive years. Elevated blood sugar levels in maternal diabetes can contribute to congenital heart disease (CHD) in babies by impacting the development of the fetal heart. These increased glucose concentrations in the mother’s bloodstream have the potential to interfere with the proper formation of the infant’s heart, thereby elevating the likelihood of CHD. To illustrate, data from October 2023, provided by the National Health Service, a UK government body, indicated that adverse pregnancy outcomes for women identified with type 2 diabetes stood at 4.9% in 2021, climbing to 6.6% in 2022. Consequently, the growing prevalence of maternal diabetes cases is propelling the expansion of the congenital heart disease (CHD) market.
What Are The Major Segment Categories Driving The Congenital Heart Disease (CHD) Market Growth?
The congenital heart disease (chd)market covered in this report is segmented –
1) By Type: Heart Valve Defects; Heart Wall Defects; Blood Vessel Defects; Other Types
2) By Diagnosis: Electrocardiogram; Chest X-ray; Echocardiogram; Transesophageal Echocardiogram; Pulse Oximetry; Exercise Stress Test; Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI); Cardiac Catheterization; Other Diagnosis
3) By Treatment: Interventional Cardiology; Cardiac Surgery; Telemedicine; Medication Management; Lifestyle Modifications
4) By Age Group: Infants; Children; Adolescents; Adults
5) By Application: Hospitals And Clinics; Diagnostic Centers; Ambulatory Surgical Centers; Research And Academic Institutions
Subsegments:
1) By Heart Valve Defects: Aortic Valve Stenosis; Pulmonary Valve Stenosis; Mitral Valve Prolapse; Tricuspid Valve Defects; Valve Regurgitation
2) By Heart Wall Defects: Atrial Septal Defect (ASD); Ventricular Septal Defect (VSD); Atrioventricular Septal Defect (AVSD); Hypoplastic Left Heart Syndrome (HLHS); Tetralogy of Fallot (TOF)
3) By Blood Vessel Defects: Coarctation Of The Aorta; Patent Ductus Arteriosus (PDA); Pulmonary Artery Stenosis; Transposition Of The Great Arteries (TGA); Truncus Arteriosus
4) By Other Types: Single Ventricle Defects; Ebstein’s Anomaly; Total Anomalous Pulmonary Venous Return (TAPVR); Coronary Artery Anomalies; Pulmonary Venous Obstruction
Which Competitive Trends Are Defining The Congenital Heart Disease (CHD) Market Structure?
Leading companies within the congenital heart disease market are actively developing non-surgical heart valves to enhance patient outcomes and improve their quality of life. These non-surgical heart valves, also referred to as transcatheter valves, are medical devices designed to treat heart valve conditions without the necessity of traditional open-heart surgery. For instance, in February 2023, Medtronic, a US-based medical technology company, relaunched its Harmony Transcatheter Pulmonary Valve (TPV) System. This system provides a groundbreaking, minimally invasive alternative to open-heart surgery for patients with congenital heart disease, specifically those presenting with native or surgically repaired right ventricular outflow tract (RVOT) anomalies. This system holds the distinction of being the first FDA-approved valve engineered for the right side, offering a non-surgical remedy for individuals experiencing severe pulmonary valve regurgitation. The Harmony TPV System originally secured U.S. FDA approval in 2021. Its reintroduction, following a voluntary recall, underscores Medtronic’s commitment to advancing solutions for patients with congenital heart disease.
Who Are The Core Companies Influencing The Congenital Heart Disease (CHD) Market Landscape?
Major companies operating in the congenital heart disease (CHD) market are Pfizer Inc., AstraZeneca Plc, Abbott Laboratories, Novartis AG, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Neusoft Corp., Carestream Health, Midmark Corporation, Contec Medical Systems, Randox Laboratories Ltd., Schiller AG, BPL Medical Technologies, Compumedics Limited, Biocare Medical, Bionet America Inc., Nasan Medical Electronics Pvt Ltd
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/congenital-heart-disease-chd-global-market-report
How Do Regional Market Performances Compare Within The Congenital Heart Disease (CHD) Industry?
North America was the largest region in the congenital heart disease (CHD) market in 2024. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Congenital Heart Disease (CHD) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15545&type=smp
Browse Through More Reports Similar to the Global Congenital Heart Disease (CHD) Market 2025, By The Business Research Company
Cardiovascular Ultrasound Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiovascular-ultrasound-global-market-report
Cardiovascular Surgery Devices And Equipment Global Market Report 2025
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model